There is a wide time gap between the publication of evidence and the application of new knowledge into routine clinical practice. The consequence is sub-optimal outcomes, particularly concerning for long-term relapsing/remitting conditions such as allergic diseases. In response, there has been a proliferation of published guidelines which systematically review evidence for the gold-standard management of most allergic disorders. However, this has not necessarily been followed by improved outcomes, partly due to a lack of coordination across the patient pathway. This has become known as the "second translational gap". A proposed solution is the development and implementation of integrated care pathways (ICPs) to optimize patient outcomes, wi...
International audiencePrecision medicine (PM) is increasingly recognized as the way forward for opti...
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focu...
Allergic diseases and asthma are increasing in prevalence globally. They can start early in life and...
There is a wide time gap between the publication of evidence and the application of new knowledge in...
There is a wide time gap between the publication of evidence and the application of new knowledge in...
Background: Guidelines for management of patients with allergic conditions are available, but the ad...
Background: GA2LEN-ADCARE is a branch of the largest multidisciplinary network of research centres a...
Objectives The incidence and prevalence of allergies worldwide has been increasing and allergy servi...
The incidence, prevalence and costs of allergy have increased substantially in recent decades in man...
national care pathways for children with allergies. The eczema pathway focuses on defi ning the comp...
The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, i...
Allergic diseases are characterized by a complex complex chronic pathophysiology. Therapeutic patien...
Background: Hymenoptera venom allergy (HVA) is an underestimated condition representing an important...
Background: Diagnosis and management of allergic patients is often initially and exclusively perform...
International audienceIn all societies, the burden and cost of allergic and chronic respiratory dise...
International audiencePrecision medicine (PM) is increasingly recognized as the way forward for opti...
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focu...
Allergic diseases and asthma are increasing in prevalence globally. They can start early in life and...
There is a wide time gap between the publication of evidence and the application of new knowledge in...
There is a wide time gap between the publication of evidence and the application of new knowledge in...
Background: Guidelines for management of patients with allergic conditions are available, but the ad...
Background: GA2LEN-ADCARE is a branch of the largest multidisciplinary network of research centres a...
Objectives The incidence and prevalence of allergies worldwide has been increasing and allergy servi...
The incidence, prevalence and costs of allergy have increased substantially in recent decades in man...
national care pathways for children with allergies. The eczema pathway focuses on defi ning the comp...
The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, i...
Allergic diseases are characterized by a complex complex chronic pathophysiology. Therapeutic patien...
Background: Hymenoptera venom allergy (HVA) is an underestimated condition representing an important...
Background: Diagnosis and management of allergic patients is often initially and exclusively perform...
International audienceIn all societies, the burden and cost of allergic and chronic respiratory dise...
International audiencePrecision medicine (PM) is increasingly recognized as the way forward for opti...
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focu...
Allergic diseases and asthma are increasing in prevalence globally. They can start early in life and...